Carregant...
Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Avail...
Guardat en:
| Publicat a: | Curr Probl Cardiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mosby-Year Book
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320667/ https://ncbi.nlm.nih.gov/pubmed/32703535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cpcardiol.2020.100648 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|